Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
celgene
life sciences
national blog main
new york
new york blog main
new york top stories
3
×
anemia
beta-thalassemia
boston blog main
fda
luspatercept
rare diseases
acceleron pharma
acceleron pharmaceuticals
acquisition
boston top stories
bristol-myers squibb
buyout
clinical trials
clinical trials fda
drug discovery
drugs
life science
m&a
merger
ms
multiple sclerosis
myelodysplastic syndrome
myelodysplastic syndrome (mds)
myelofibrosis
ozanimod
rare disease drugs
receptos
red blood cells
regulatory filing
san diego blog main
uc
What
approval
3
×
celgene
3
×
drug
fda
3
×
blood
experimental
pipeline
acceleron
acquisition
added
amid
anemia
application
assets
based
celgene’s
cell
cited
developed
disease
disorder
drama
filed
files
key
levels
low
monday
ms
multiple
nasdaq
nj
ozanimod
patients
pharma
rare
red
regulatory
resubmits
sclerosis
Language
unset
Current search:
approval
×
fda
×
" new york top stories "
×
celgene
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}